Haleon PLC Sponsored ADR (NYSE:HLN) to Issue $0.13 Dividend

Haleon PLC Sponsored ADR (NYSE:HLN) announced a dividend on Wednesday, February 25th. Investors of record on Friday, April 10th will be paid a dividend of 0.1307 per share on Thursday, May 14th. This represents a dividend yield of 251.0%. The ex-dividend date is Friday, April 10th.

Haleon has a payout ratio of 20.4% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Haleon to earn $0.49 per share next year, which means the company should continue to be able to cover its $0.11 annual dividend with an expected future payout ratio of 22.4%.

Haleon Trading Up 2.8%

Shares of HLN traded up $0.30 during mid-day trading on Thursday, reaching $10.74. 7,703,209 shares of the company were exchanged, compared to its average volume of 8,596,493. The business has a 50 day simple moving average of $10.42 and a two-hundred day simple moving average of $9.80. Haleon has a 52 week low of $8.71 and a 52 week high of $11.42. The stock has a market capitalization of $47.81 billion, a PE ratio of 27.53 and a beta of 0.19. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.63 and a current ratio of 0.87.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Jefferies Financial Group reissued a “buy” rating on shares of Haleon in a research note on Tuesday, January 20th. Morgan Stanley reissued an “overweight” rating on shares of Haleon in a research note on Monday, December 15th. HSBC raised Haleon from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, January 21st. Deutsche Bank Aktiengesellschaft lowered Haleon from a “hold” rating to a “sell” rating in a research note on Monday, January 12th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Haleon in a research report on Thursday, January 22nd. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Haleon has an average rating of “Moderate Buy” and a consensus target price of $12.33.

Haleon Company Profile

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.